Gilead’s remdesivir has shown early promise treating COVID-19 patients. Patients involved in the clinical trial have shown rapid recoveries in fever and respiratory symptoms and nearly all patients in the trial were discharged in less than a week. (STAT)
Abbott’s rapid COVID-19 test may produce false negative results. The test, which was touted by President Trump, can give results in 13 minutes. The false results may be driven by the samples collected from patients and Abbott said it has issued new guidelines for how samples are collected. (STAT)
GE and Ford will produce 50,000 ventilators for the U.S. government. The two companies signed a $336 million contract to produce ventilators. They expect all of the ventilators to be finished by July 13. (CNBC)
Anti-anxiety medication prescriptions jumped 34% due to coronavirus pandemic. Prescriptions for insomnia medication increased 14.8%, and antidepressants jumped 18.6%, according to a report from Express Scripts tracking prescription data from January 1 to March 15. (MarketWatch)
Biogen has created a coronavirus biobank. Some company employees who were infected with COVID-19 have contributed blood samples and other data to the biobank. About 100 Biogen employees contracted the illness after a leadership meeting at the company’s headquarters in March. (BioPharma Dive)
The post Five things for pharma marketers to know: Friday, April 17, 2020 appeared first on MM&M – Medical Marketing and Media.
more recommended stories
Inflatable Neurostimulator for Minimally Invasive Pain Control
Researchers at the University of Cambridge.
Glucagon-like Peptide-1 Metabolism is Impacted by Anthocyanins and (-)-epicatechin
Obesity and diabetes are major health.
The latest science on staying healthy during pregnancy
New research examines prenatal supplements, how.
Relapsed, Refractory Follicular Lymphoma: CAR-T Cell Therapy Shows Promise
Axicabtagene ciloleucel (axi-cel) appears to be.
DLBCL: Naratuximab Shows Promise Among Patients With Relapsed/Refractory Disease
Among patients with diffuse large B.
Quasiprobabilities Shed Light on Quantum Advantage
Quantum advantage is a hot topic,.
Why patient-focused innovation matters
Professor David Barrett, lead consultant at.
Pembrolizumab After RCC Surgery: Potential New Standard of Care
Pembrolizumab following surgery for clear cell.
The Link Between Too Much Caffeine and Glaucoma
Consuming large amounts of daily caffeine.
Scientists Find Gene Mutation Linked to Exfoliation Syndrome
Exfoliation syndrome (XFS) is an age-related,.